Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000912057-01-007596
Filing Date
2001-03-14
Accepted
2001-03-14 00:00:00
Documents
7
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 10-K405 a2040379z10-k405.htm 10-K405 455609
2 EXHIBIT 10.31 a2040379zex-10_31.htm EX-10.31 330606
3 EXHIBIT 10.32 a2040379zex-10_32.htm EX-10.32 29798
4 EXHIBIT 10.33 a2040379zex-10_33.htm EX-10.33 54395
5 SUBSIDIARY LIST a2040379zex-21_.htm EX-21. 4764
6 CONSENT OF PRICE WATERHOUSE a2040379zex-23_.htm EX-23. 2281
7 G856670.JPG g856670.jpg GRAPHIC 3949
  Complete submission text file 0000912057-01-007596.txt   883745
Mailing Address CORNING PHARMACEUTICAL SERVICES INC 210 CARNEGIE CENTER PRINCETON NJ 08540
Business Address 210 CARNEGIE CENTER PRINCETON NJ 08540 6094524440
COVANCE INC (Filer) CIK: 0001023131 (see all company filings)

EIN.: 223265977 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 001-12213 | Film No.: 1568200
SIC: 8731 Services-Commercial Physical & Biological Research